Organization
Clearside Biomedical
3 clinical trials
Clinical trial
Extension Study to Evaluate the Long-term Outcomes of Subjects Following CLS-AX Administration for Age-related Macular Degeneration in the CLS-AX CLS1002-101 StudyStatus: Completed, Estimated PCD: 2023-01-05
Clinical trial
OASIS: Open-label, Dose-escalation, Phase 1/2a Study of the Safety and Tolerability of Suprachoroidally Administered CLS-AX Following Intravitreal Anti-VEGF Therapy in Subjects With Neovascular Age-related Macular DegenerationStatus: Completed, Estimated PCD: 2022-10-13
Clinical trial
ODYSSEY: A Phase 2b Study of Suprachoroidally Administered CLS-AX in Participants With Neovascular Age-Related Macular DegenerationStatus: Active (not recruiting), Estimated PCD: 2024-07-01